The primary purpose of treating chronic hepatitis C (HCV) is to prevent the development of liver fibrosis, cirrhosis, and cancer. In the last decade, direct-acting antiviral medicine (DAA) has been approved to treat children with HCV. This treatment has a higher efficacy, shorter duration, and milder side effects than the previously approved treatment. In this review, it is recommended to track down children who might be infected with HCV to enhance early treatment to prevent transmission of the virus and the possible complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.61409/V08230522 | DOI Listing |
Publication Analysis
Top Keywords
[not available]
4
available] primary
4
primary purpose
4
purpose treating
4
treating chronic
4
chronic hepatitis
4
hepatitis hcv
4
hcv prevent
4
prevent development
4
development liver
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!